Vera Therapeutics, Inc.
VERA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001831828
In the last 90 days, Vera Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 219 institutions reported holding it in 13F filings for Q2 2026, worth $3.34B in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Vera Therapeutics, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 37
- +7 vs. Q3 2021
- Shares held
- 14.1M
- +687.2K (+5.1%) vs. Q3 2021
- Total value
- $374.9M
- +$145.8M (+63.6%) vs. Q3 2021
- New holders
- 7
- 20 more added
- Sold out
- 0
- 5 more reduced
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VERA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 219 | $3.34B |
| Q1 2026 | 229 | $2.92B |
| Q4 2025 | 214 | $3.75B |
| Q3 2025 | 176 | $1.89B |
| Q2 2025 | 172 | $1.51B |
| Q1 2025 | 179 | $1.52B |
| Q4 2024 | 178 | $2.66B |
| Q3 2024 | 173 | $2.37B |
| Q2 2024 | 171 | $1.92B |
| Q1 2024 | 159 | $2.21B |
| Q4 2023 | 95 | $637.2M |
| Q3 2023 | 84 | $538.2M |
| Q2 2023 | 76 | $611.9M |
| Q1 2023 | 70 | $289.7M |
| Q4 2022 | 59 | $412.8M |
| Q3 2022 | 55 | $459.0M |
| Q2 2022 | 51 | $277.6M |
| Q1 2022 | 50 | $468.9M |
| Q4 2021 | 37 | $374.9M |
| Q3 2021 | 31 | $252.4M |
| Q2 2021 | 22 | $186.1M |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Vera Therapeutics, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Tower Research Capital LLC (TRC) | 538 | $14.0K | 0.00% | −67−11.1% | Reduced |
| Ameritas Investment Partners, Inc. | 542 | $14.0K | 0.00% | 00.0% | Unchanged |
| Legal & General Group Plc | 933 | $25.0K | 0.00% | +271+40.9% | Added |
| STRS Ohio | 1,600 | $42.0K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 2,657 | $71.0K | 0.00% | +1,847+228.0% | Added |
| Royal Bank of Canada | 2,696 | $72.0K | 0.00% | +1,916+245.6% | Added |
| American International Group, Inc. | 5,259 | $141.0K | 0.00% | +1,392+36.0% | Added |
| California State Teachers Retirement System | 5,416 | $145.0K | 0.00% | +1,599+41.9% | Added |
| Wells Fargo & Company | 5,697 | $152.0K | 0.00% | +5,650+12,021.3% | Added |
| Deutsche Bank AG | 6,013 | $161.0K | 0.00% | +1,945+47.8% | Added |
| New York State Common Retirement Fund | 6,549 | $175.0K | 0.00% | +5,349+445.7% | Added |
| Jane Street Group, LLC | 8,287 | $221.0K | 0.00% | +8,287 | New |
| Cambridge Trust Co | 9,887 | $264.0K | 0.01% | +9,887 | New |
| Bank of America Corp | 11,907 | $318.0K | 0.00% | +5,386+82.6% | Added |
| Nuveen Asset Management, LLC | 15,098 | $344.0K | 0.00% | +15,098 | New |
| Raymond James Financial Services Advisors, Inc. | 17,828 | $476.0K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 20,589 | $550.0K | 0.00% | +7,365+55.7% | Added |
| Parkman Healthcare Partners LLC | 21,555 | $576.0K | 0.13% | −4,083−15.9% | Reduced |
| Charles Schwab Investment Management Inc | 23,492 | $628.0K | 0.00% | +6,544+38.6% | Added |
| Gyon Technologies Capital Management, LP | 24,553 | $656.0K | 0.12% | +5,511+28.9% | Added |
| Morgan Stanley | 26,691 | $714.0K | 0.00% | +4,685+21.3% | Added |
| Carnegie Mellon University | 32,120 | $858.0K | 0.34% | +32,120 | New |
| Logos Global Management LP | 50,000 | $1.34M | 0.14% | +50,000 | New |
| JPMorgan Chase & Co | 76,126 | $2.04M | 0.00% | −2,526−3.2% | Reduced |
| Northern Trust Corp | 77,853 | $2.08M | 0.00% | +18,538+31.3% | Added |
| International Biotechnology Trust PLC | 120,535 | $3.20M | 0.71% | +120,535 | New |
| Geode Capital Management, LLC | 121,582 | $3.25M | 0.00% | +49,974+69.8% | Added |
| State Street Corp | 123,273 | $3.29M | 0.00% | +48,018+63.8% | Added |
| Kynam Capital Management, LP | 253,449 | $6.77M | 3.62% | +253,449 | New |
| Vanguard Group Inc | 388,978 | $10.4M | 0.00% | +143,143+58.2% | Added |
| BlackRock Inc. | 455,100 | $12.2M | 0.00% | +141,063+44.9% | Added |
| Octagon Capital Advisors LP | 670,940 | $17.9M | 3.49% | −25,186−3.6% | Reduced |
| Alphabet Inc. | 713,658 | $19.1M | 0.46% | −231,133−24.5% | Reduced |
| Citadel Advisors LLC | 1,733,182 | $46.3M | 0.05% | +4,834+0.3% | Added |
| Sofinnova Investments, Inc. | 2,914,776 | $77.9M | 4.99% | 00.0% | Unchanged |
| Abingworth LLP | 2,960,231 | $78.5M | 19.03% | 00.0% | Unchanged |
| FMR LLC | 3,145,202 | $84.0M | 0.01% | +5,800+0.2% | Added |
| KPCB XVI Associates, LLC | – | – | – | – | Not filed |